Boston Scientific Corporation (BSX) Hit a 52 Week High, Can the Run Continue?
Boston Scientific (BSX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Boston Scientific (BSX) Falls More Steeply Than Broader Market: What Investors Need to Know
Boston Scientific (BSX) reachead $86.20 at the closing of the latest trading day, reflecting a -0.58% change compared to its last close.
Why Boston Scientific (BSX) Outpaced the Stock Market Today
Boston Scientific (BSX) closed at $84.49 in the latest trading session, marking a +0.42% move from the prior day.
3 MedTech Stocks to Buy as Monetary Policy Eases
Here, we pick three MedTech stocks, VCYT, BSX and PAHC, which are anticipated to gain strongly in 2024 from the loosening of monetary policy.
BSX Stock Gains From FARAPULSE PFA's PMDA Approval in Japan
Boston Scientific achieves PMDA approval for its FARAPULSE PFA System in Japan. The company expects to launch the system in the country in the upcoming weeks.
Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors
Boston Scientific (BSX) closed at $83.08 in the latest trading session, marking a -0.5% move from the prior day.
Boston Scientific (BSX) Rises But Trails Market: What Investors Should Know
Boston Scientific (BSX) closed at $84 in the latest trading session, marking a +0.1% move from the prior day.
Is Boston Scientific (BSX) a Solid Growth Stock? 3 Reasons to Think "Yes"
Boston Scientific (BSX) possesses solid growth attributes, which could help it handily outperform the market.
Boston Scientific Corporation (BSX) Soars to 52-Week High, Time to Cash Out?
Boston Scientific (BSX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Here's Why Boston Scientific (BSX) is a Strong Growth Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
BSX Gets FDA Nod on INGEVITY+ Pacing Lead in the LBBA: Stock to Gain?
Boston Scientific received FDA approval on the expanded indication for INGEVITY+ Pacing Leads. Data demonstrated this lead to be safe and effective for LBBA pacing.
Boston Scientific (BSX) Stock Dips While Market Gains: Key Facts
In the closing of the recent trading day, Boston Scientific (BSX) stood at $82.94, denoting a -0.14% change from the preceding trading day.
Boston Scientific Corporation (BSX) Wells Fargo 2024 Healthcare Conference (Transcript)
Boston Scientific Corporation (NYSE:BSX ) Wells Fargo 2024 Healthcare Conference September 4, 2024 8:00 AM ET Company Participants Brad Sutton - Chief Medical Officer, AF Solutions Jon Monson - SVP...
Boston Scientific's ACURATE Prime Aortic Valve System Wins CE Mark
BSX achieves CE Mark approval for the ACURATE Prime Aortic Valve System, its latest TAVR technology.
Boston Scientific (BSX) is an Incredible Growth Stock: 3 Reasons Why
Boston Scientific (BSX) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Related Companies